ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
16,860.00
-0.84%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.22
-0.39%
Bitcoin
64,276.57
-3.21%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Inventiva Sa (0RNK) Quote

Inventiva Sa

Inventiva Sa (0RNK)

LSE
7.62
0.00
(0.00%)
Closed April 24 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
7.62
Bid
0.00
Ask
0.00
Volume
90
0.00 Day's Range 0.00
7.62 52 Week Range 7.62
Market Cap
157.39M
Previous Close
7.62
Open
-
Last Trade
90
@
3.01983
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
809
Shares Outstanding
52,116,000
Dividend Yield
-
PE Ratio
-1.43
Earnings Per Share (EPS)
-2.12
Revenue
23.16M
Net Profit
-110.43M

About Inventiva Sa

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.inventivapharma.com
Headquarters
Daix, Fra
Founded
1970
Inventiva Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 52,116,000 shares outstanding. The market capitalization of Inventiva is 157.39 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.43.

0RNK Latest News

More News

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son Rapport Annuel 2023 (« Form 20-F »)

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son Rapport Annuel 2023 (« Form 20-F ») Daix (France), Long Island City (New York, United States), le 3 avril...

April 03 2024
GlobeNewswire Inc.

Inventiva announces the nomination of Andre Turenne as Director

Inventiva announces the nomination of Andre Turenne as Director Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the...

March 28 2024
GlobeNewswire Inc.

Inventiva publie ses résultats annuels 2023

Inventiva publie ses résultats annuels 2023 Chiffre d’affaires de 17,5 millions d’euros pour l’année 2023, en hausse de 43,4 % par rapport à 12,2 millions d’euros en 2022Trésorerie et...

March 27 2024
GlobeNewswire Inc.

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results Daix (France), Long Island City (New York, United States), March 22, 2024 – Inventiva...

March 22 2024
GlobeNewswire Inc.

Inventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète de type 2

Inventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète...

March 18 2024
UK Regulatory

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D

Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D LEGEND achieved its primary...

March 18 2024
UK Regulatory

Inventiva annonce la présentation des résultats de son étude clinique de Phase IIa LEGEND combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de DT2

Inventiva annonce la présentation des résultats de son étude clinique de Phase IIa LEGEND combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de DT2 Daix (France...

March 13 2024
UK Regulatory

Inventiva to present the results of LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with MASH/NASH and T2D

Inventiva to present the results of LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with MASH/NASH and T2D Daix (France), Long Island City (New York, United...

March 13 2024
UK Regulatory

Inventiva annonce la reprise du screening dans l’étude clinique de Phase III, NATiV3, évaluant lanifibranor dans la NASH  

Inventiva annonce la reprise du screening dans l’étude clinique de Phase III, NATiV3, évaluant lanifibranor dans la NASH   Inventiva a levé la pause volontaire du screening et de la randomisation...

March 07 2024
UK Regulatory

Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed

Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed Inventiva has lifted the voluntary pause on screening and randomization in...

March 07 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.627.627.62357.62DE
4007.627.627.6210947.62DE
12007.627.627.628097.62DE
26007.627.627.6213817.62DE
52007.627.627.6248237.62DE
156007.627.627.6228117.62DE
260007.627.627.6247297.62DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIREreAlpha Tech Corporation
$ 1.70
(46.55%)
4.78M
CDTXCidara Therapeutics Inc
$ 16.70
(35.88%)
219.82k
ILAGIntelligent Living Application Group Inc
$ 0.72
(33.33%)
1.82M
THMOThermoGenesis Holdings Inc
$ 0.80
(23.08%)
1.46k
NUWENewellis Inc
$ 0.2994
(18.76%)
1.73M
FBLGraniteShares ETF Trust GraniteShares
$ 18.05
(-32.57%)
1.47M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.316
(-25.70%)
6.79M
METAMeta Platforms Inc
$ 412.50
(-16.41%)
10.73M
ESGLESGL Holdings Ltd
$ 0.55
(-12.88%)
523.48k
AKLIAkili Inc
$ 0.221
(-10.89%)
5k
METAMeta Platforms Inc
$ 412.50
(-16.41%)
10.73M
SQQQProShares UltraPro Short QQQ
$ 12.28
(3.98%)
10.51M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.316
(-25.70%)
6.79M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0498
(-0.20%)
5.48M
HCPHashiCorp Inc
$ 32.90
(4.74%)
5.22M

Discussion

View Full Feed
linkvest linkvest 5 minutes ago
Folks just read his posting to learn he's not an investor but just a loser that goes board to board to bash to feed his tiny ego... loser for sure.
IGPK
johnnytrader33 johnnytrader33 5 minutes ago
hey um this post? Kinda didn't age well right?
TSOI
NYBob NYBob 6 minutes ago
Equinox Gold's CFO, Peter Hardie presenting at the Gold Forum Europe in Zurich
Equinox Gold Corp.
1.04K subscribers

[YT]6Np6zk00EDA[/YT]
EQX
Huggy Bear Huggy Bear 6 minutes ago
How are you "earning" anything? Are you dumping shares that aren't even fundamentally worth .0001 on fresh marks?
SPZI
norisknorewards norisknorewards 6 minutes ago
Same, just. Same.

Wait and see, I continue buying, lowest recently around .50.

Not fussed it's lower now, I'll keep buying bits and pieces. Hell, I've put in anywhere from 300 bucks to 10k in various transactions.

300 at .5 is 600+ shares, 600 shares, ev
NWBO
TreasuredTrades TreasuredTrades 6 minutes ago
Could someone do some fact finding on this: "Matt Moore and his wife have been hiding out in an apartment in southern California for months. This is the reason Matt Moore is unable to be served."
INND
tdbowieknife tdbowieknife 7 minutes ago
I figured that would happen. They had major problems with building the data center too. The folks in the area didn't want it around.

https://lawrencekstimes.com/2023/02/28/mclouth-crypto-moratorium/

I'm sure they have no money. Haven't been paying much attention to this
PLFF
ilovetech ilovetech 7 minutes ago
Zadie420 - Now that's a bit drastic for a forward looking statement. My confidence in getting to a much higher valuation than the number you're suggesting is simply because, it's LP running the show. As much as I'm incensed regarding the daily unchecked criminal enterprise, I remain focused on the b
NWBO
Chartmaster Chartmaster 7 minutes ago
Checkout this daily chart showing the Pennant Breakout today!

https://investorshub.advfn.com/uimage/uploads/2024/4/24/ipmvqNSAV_4-24-24.PNG

And this weekly 100 day breakout! Dual breakouts on both daily and weekly Charts!

https://investorshub.advfn.com/ui
NSAV
loanshark007 loanshark007 7 minutes ago
This place is filled with scumbag con artist. The board has a used car lot feel to it.

SCAM
IGPK
Short Squeeze Short Squeeze 8 minutes ago
That law suit was BS I hope he sues GS CAP and files a complaint with the SEC. There’s 0 chance that they would be able to sell without a waiting period.
BEGI
Willy Willy 8 minutes ago
And now those calls are worthless.
META
I-Glow I-Glow 8 minutes ago
You love to pickup a buzzword and ride it much like the nonsense of naked shorting - you posted many times that WNFT had been naked shorted 500 million shares but never provided and facts/proof.

IG
WNFT
hvp hvp 8 minutes ago
🤣🤣🤣🤣🤣🤣
ENZC
GetRichLong GetRichLong 8 minutes ago
Same nonsense, different year. Never seeing 0.01 unless it reverse splits in this lifetime. Hold those bags!
AHRO
Countmein Countmein 8 minutes ago
Closed @ 24.80 on 890,554 volume

Count
HOMB
Techroemancer Techroemancer 9 minutes ago
You're posting off-topic posts. It's my job as a board moderator to remove that content. Please, feel free to challenge anything I remove if you feel as though it was removed unjustly.

Additionally, I'd encourage you to look at the evidence of many rather than the spiteful retaliation
MGON
RealDutch RealDutch 9 minutes ago
It's time to deliver Laxmi, and I mean it. Execute.... I don't think anyone cares about this soothing talk anymore.
ITUP
Countmein Countmein 9 minutes ago
Home BancShares, Inc. Announces Second Quarter Cash Dividend
https://ih.advfn.com/stock-market/NYSE/home-bancshares-HOMB/stock-news/93709464/home-bancshares-inc-announces-second-quarter-cas

Count
HOMB
dreamaker56 dreamaker56 9 minutes ago
I believe you are correct. The actual problem is not access it was the new OTC rules per IGPK update. They had to change name back in order for Financials to be accepted.

$IGPK DOES HAVE OTC ACCESS
IGPK
Cowboy1966 Cowboy1966 9 minutes ago
This has nothing to do with APRU
APRU
4OurRetirement 4OurRetirement 9 minutes ago
"Immaterial" Also Implies, The PPS Crash From $8's...

$20's & Also Possibly The $30's!...

Were All Over Reactions And Market Manipulation!

I'm Holding To See Rebound From This Fiasco,
Which, As Far As I'm Concerned,
Could Have Been All Plann
CDMO
Rubberneck2 Rubberneck2 10 minutes ago
Sounds promising!
CNNA
spec machine spec machine 10 minutes ago
Are you any closer to grasping the real direction here?

I think my past posts probably were more accurate than someone writing a puff review on a phony stock analyst board

If you lose a bunch of money, at least accept the lesson

spec
CLNE

Your Recent History

LSE
0RNK
Inventiva
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved